Importation Threatens American Patients
December 19, 2019 Today, the Food and Drug Administration (FDA) issued a notice of proposed rulemaking to allow the importation...
CASE VIDEO: Democrats Put Politics Over America with USMCA
December 11, 2019 In what could be the policy hallmark of his first term in office, President Trump has...
CASE Joins Coalition of 75 Free-Market Groups Opposed to “Medicare for All” Styled Price-Fixing Schemes
December 5, 2019 Click Here to see full coalition letter. Text of Letter: We represent fiscal conservatives and free...
Don’t Smoke ‘Em if You Got ‘Em – Pelosi Drug Pricing Bill is Like Two Pack-a-Day Habit
December 4, 2019 A new report issued this week by the President’s Council of Economic Advisers (CEA) provides a startling snapshot of...
Rep. Dan Crenshaw Breaks Down Why H.R.3 is a Dangerous Idea
“I don’t think people would be supportive of this idea if they realized there would be so many fewer cures.”...
CASE Op-Ed – Washington Times: What To Do About Prescription Drug Prices
Matthew Kandrach – President, CASE November 7, 2019 Few policy issues have consumed Washington more over the past year...
At Medicare Open Enrollment: A Warning On Socialized Medicine
This month, millions of seniors will take advantage of the Medicare open enrollment period, shopping for Medicare Advantage and Medicare...
CASE Op-Ed – InsideSources: Government Mandates Are Wrong Solution to Surprise Medical Bills
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
Cicilline Patent Bill Will Prove Devastating to Advancing Improvements in Medicine
Gerard Scimeca – Chairman, CASE October 4, 2019 America has long led the world in groundbreaking innovation and life-altering inventions....
In The House of Representatives – Few Cures, Many Ills on Drug Pricing
Yesterday, the House Energy and Commerce Committee debated the merits of H.R.3, a proposal released by Speaker of the House...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/